Zobrazeno 1 - 10
of 288
pro vyhledávání: '"hemagglutinin (HA)"'
Publikováno v:
Guangdong nongye kexue, Vol 50, Iss 10, Pp 149-156 (2023)
【Objective】The experiment is aimed to express the HA protein of H7 subtype avian influenza virus (AIV) in eukaryotic cells, in order to provide bass for futher preparation of H7 subunit vaccine and evaluation of their immunogenicity.【Method】F
Externí odkaz:
https://doaj.org/article/663e41946a3341fcad75ac7963dcee9b
Publikováno v:
Vaccines, Vol 12, Iss 7, p 706 (2024)
The hemagglutinin (HA) and neuraminidase (NA) surface proteins are the primary and secondary immune targets for most influenza vaccines. In this study, H2, H5, H7, N1, and N2 antigens designed by the computationally optimized broadly reactive antigen
Externí odkaz:
https://doaj.org/article/f64192224ec149299d8b27d5c3b6e6e0
Publikováno v:
Journal of Functional Foods, Vol 112, Iss , Pp 105940- (2024)
Hoveniae Semen Seu Fructus (HSF) is a fruit and seed of Hovenia dulcis Thunb. Here, we first report HSF water extract contains a potent anti-influenza A virus (IAV) effect via inhibition of neuraminidase and hemagglutinin and a direct virus-killing e
Externí odkaz:
https://doaj.org/article/388e4824dbad4c879740a66c97c4c66a
Autor:
Bo Ryoung Park, Ramireddy Bommireddy, David Hyunjung Chung, Ki-Hye Kim, Jeeva Subbiah, Yu-Jin Jung, Noopur Bhatnagar, Christopher D. Pack, Sampath Ramachandiran, Shaker J.C. Reddy, Periasamy Selvaraj, Sang-Moo Kang
Publikováno v:
Immunity & Ageing, Vol 20, Iss 1, Pp 1-14 (2023)
Abstract Background Current influenza vaccines deliver satisfactory results in young people but are less effective in the elderly. Development of vaccines for an ever-increasing aging population has been an arduous challenge due to immunosenescence t
Externí odkaz:
https://doaj.org/article/12e4733e1ce4421c8b8858cd0e655efd
Publikováno v:
Virus Research, Vol 335, Iss , Pp 199199- (2023)
Thuja orientalis Folium (TOF) has been prescribed traditionally as an expectorant for inflammatory airway disease. In this study, we evaluated the anti-influenza A virus (IAV) activity of TOF by detecting GFP expressed by influenza A virus (A/PR/8/34
Externí odkaz:
https://doaj.org/article/320b19332afe452fa9c40a0cf5595a97
Publikováno v:
Jichu yixue yu linchuang, Vol 42, Iss 12, Pp 1885-1890 (2022)
Objective To screen and establish the optimal expression strategy of influenza virus H1N1 A/Nebraska/14/2019 HA, and lay a foundation for the development of protein vaccines. Methods The recombinant baculovirus of HA full-length, different C-terminal
Externí odkaz:
https://doaj.org/article/842586190af04957963fe52b03154e51
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
Potency testing and release of annual influenza vaccines require preparation, calibration, and distribution of reference antigens (RAs) and antisera every year, which takes an average of 8 to 12 weeks, and can be a major limiting factor in pandemic s
Externí odkaz:
https://doaj.org/article/fceb0a2b3d9d48a58ab335f0f3ee3faf
Publikováno v:
Vaccines, Vol 11, Iss 12, p 1799 (2023)
Assaying the potency of inactivated viral influenza vaccines is performed using single radial immunodiffusion, which is the globally accepted release method for potency. Under conditions of a rapidly emerging pandemic, such as the 2009 H1N1 influenza
Externí odkaz:
https://doaj.org/article/1fbde3f63a0a404eb7a34cf962b045d2
Autor:
Ruyu Xie, Huixia Zhang, Han Zhang, Changyan Li, Daqing Cui, Shujun Li, Zexing Li, Hualei Liu, Jinhai Huang
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
IntroductionThe H5N8 influenza virus is a highly pathogenic pathogen for poultry and human. Vaccination is the most effective method to control the spread of the virus right now. The traditional inactivated vaccine, though well developed and used wid
Externí odkaz:
https://doaj.org/article/a304c50727ba4694971e8cdfff53c450
Autor:
Yiqing Zheng, Yanna Guo, Yingfei Li, Bing Liang, Xiaoyuan Sun, Shijia Li, Huizhi Xia, Jihui Ping
Publikováno v:
Virology Journal, Vol 19, Iss 1, Pp 1-13 (2022)
Abstract Background In early 2020, a novel H9N2 AIV immune escape variant emerged in South China and rapidly spread throughout mainland China. The effectiveness of the current H9N2 vaccine is being challenged by emerging immune escape strains. Assess
Externí odkaz:
https://doaj.org/article/2b473b1ca4a14617a98bce62a38cec1d